US Patent 7164034 Alpha2delta ligands for fibromyalgia and other disorders

Patent 7164034 was granted and assigned to Pfizer on January, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Pfizer

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71640340

Date of Patent

January 16, 2007

Patent Application Number

107349170

Date Filed

December 12, 2003

Patent Primary Examiner

‌

Deborah D. Carr

Patent abstract

This invention relates to a method of treating a disorder selected from OCD, agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, PTSD, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia by administering a compound of the formula 1

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7164034 Alpha2delta ligands for fibromyalgia and other disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API